These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9516080)

  • 1. Type I insulin-like growth factor receptor function in breast cancer.
    Surmacz E; Guvakova MA; Nolan MK; Nicosia RF; Sciacca L
    Breast Cancer Res Treat; 1998 Feb; 47(3):255-67. PubMed ID: 9516080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the IGF-I receptor in breast cancer.
    Surmacz E
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):95-105. PubMed ID: 10791772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
    Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
    Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
    Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
    Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
    Pennisi PA; Barr V; Nunez NP; Stannard B; Le Roith D
    Cancer Res; 2002 Nov; 62(22):6529-37. PubMed ID: 12438247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
    Surmacz E; Bartucci M
    J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
    Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
    Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells.
    Goldfine ID; Papa V; Vigneri R; Siiteri P; Rosenthal S
    Breast Cancer Res Treat; 1992; 22(1):69-79. PubMed ID: 1421426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
    Surmacz E; Burgaud JL
    Clin Cancer Res; 1995 Nov; 1(11):1429-36. PubMed ID: 9815941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
    Rozen F; Pollak M
    Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
    Gable KL; Maddux BA; Penaranda C; Zavodovskaya M; Campbell MJ; Lobo M; Robinson L; Schow S; Kerner JA; Goldfine ID; Youngren JF
    Mol Cancer Ther; 2006 Apr; 5(4):1079-86. PubMed ID: 16648580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
    Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
    Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.